Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Accumulated Expenses (2016 - 2025)

Aspen Aerogels' Accumulated Expenses history spans 13 years, with the latest figure at $2.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 84.88% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Dec 2025, down 84.88%, and an annual FY2025 reading of $2.9 million, down 84.88% over the prior year.
  • Accumulated Expenses for Q4 2025 was $2.9 million at Aspen Aerogels, down from $5.1 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $26.5 million in Q3 2024, with the low at $436000.0 in Q2 2021.
  • Average Accumulated Expenses over 5 years is $9.9 million, with a median of $9.5 million recorded in 2022.
  • Year-over-year, Accumulated Expenses surged 1445.41% in 2022 and then plummeted 84.88% in 2025.
  • Tracing ASPN's Accumulated Expenses over 5 years: stood at $10.8 million in 2021, then soared by 47.92% to $16.0 million in 2022, then rose by 5.46% to $16.9 million in 2023, then grew by 14.78% to $19.4 million in 2024, then plummeted by 84.88% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for ASPN's Accumulated Expenses are $2.9 million (Q4 2025), $5.1 million (Q3 2025), and $4.5 million (Q2 2025).